Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging โฅ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
PHASE3
The purpose of this study is to investigate the efficacy of selective COX-I...